Effect of Glycine on
Helicobacter pylori
In Vitro
-
Published:2004-10
Issue:10
Volume:48
Page:3782-3788
-
ISSN:0066-4804
-
Container-title:Antimicrobial Agents and Chemotherapy
-
language:en
-
Short-container-title:Antimicrob Agents Chemother
Author:
Minami Masaaki12, Ando Takafumi1, Hashikawa Shin-nosuke2, Torii Keizo2, Hasegawa Tadao2, Israel Dawn A.3, Ina Kenji1, Kusugami Kazuo1, Goto Hidemi1, Ohta Michio2
Affiliation:
1. Department of Therapeutic Medicine 2. Department of Molecular Bacteriology, Nagoya University Graduate School of Medicine, Nagoya, Japan 3. Division of Gastroenterology, Department of Medicine, Vanderbilt University Medical Center, Nashville, Tennessee
Abstract
ABSTRACT
Glycine is the simplest amino acid and is used as a metabolic product in some bacteria. However, an excess of glycine inhibits the growth of many bacteria, and it is used as a nonspecific antiseptic agent due to its low level of toxicity in animals. The effect of glycine on
Helicobacter pylori
is not precisely known. The present study was conducted to investigate (i) the effect of glycine on clarithromycin (CLR)-resistant and -susceptible strains of
H. pylori
, (ii) the effect of glycine in combination with amoxicillin (AMX), and (iii) the postantibiotic effect (PAE). The MIC at which 90% of strains are inhibited for glycine was almost 2.5 mg/ml for 31 strains of
H. pylori
, including CLR-resistant strains. We constructed isogenic CLR-resistant mutant strains by natural transformation and investigated the difference between clinical wild-type strains and isogenic mutants. There were no differences in the MICs between CLR-resistant and -susceptible strains or between clinical wild-type and mutant strains. The combination of AMX and glycine showed synergistic activity, with the minimum bactericidal concentration of AMX with glycine decreasing to 1/10 that of AMX alone. Glycine showed no PAE against
H. pylori
. These results suggest that glycine may be a useful antimicrobial agent against
H. pylori
not only alone but also in combination with antibacterial drugs for the treatment of
H. pylori
-associated diseases. Glycine may represent a component of a new type of eradication therapy for CLR-resistant
H. pylori
.
Publisher
American Society for Microbiology
Subject
Infectious Diseases,Pharmacology (medical),Pharmacology
Reference40 articles.
1. Adamek, R. J., S. Suerbaum, and B. Pffaffenbach. 1998. Primary and acquired Helicobacter pylori resistance to clarithromycin, metronidazole, and amoxicillin—influence on treatment outcome. Am. J. Gastroenterol.93:386-389. 2. Alm, R. A., L. S. Ling, D. T. Moir, B. L. King, E. D. Brown, P. C. Doig, D. R. Smith, B. Noonan, B. C. Guild, B. L. deJonge, G. Carmel, P. J. Tummino, A. Caruso, M. Uria-Nickelsen, D. M. Mills, C. Ives, R. Gibson, D. Merberg, S. D. Mills, Q. Jiang, D. E. Taylor, G. F. Vovis, and T. J. Trust. 1999. Genomic-sequence comparison of two unrelated isolates of the human gastric pathogen Helicobacter pylori. Nature397:176-180. 3. HP0333, a Member of the
dprA
Family, Is Involved in Natural Transformation in
Helicobacter pylori 4. Ando, T., Q. Xu, M. Torres, K. Kusugami, D. A. Israel, and M. J. Blaser. 2000. Restriction-modification system differences in Helicobacter pylori are a barrier to interstrain plasmid transfer. Mol. Microbiol.37:1052-1065. 5. Asaka, M., T. Sugiyama, M. Kato, K. Satoh, H. Kawayama, Y. Fukuda, T. Fujioka, T. Takemoto, K. Kimura, T. Shimoyama, K. Shimizu, and S. Kobayashi. 2001. A multi center, double-blind study on triple therapy with lansoprazole, amoxicillin and clarithromycin for eradication of Helicobacter pylori in Japanese peptic ulcer patients. Helicobacter6:254-261.
Cited by
35 articles.
订阅此论文施引文献
订阅此论文施引文献,注册后可以免费订阅5篇论文的施引文献,订阅后可以查看论文全部施引文献
|
|